KESTRA MEDICAL TECHNOLOGIES (KMTS) Stock Overview
USA - NASDAQ:KMTS - BMG524411052 - Common Stock
KMTS Key Statistics, Chart & Performance
The current stock price of KMTS is 24.23 USD. In the past month the price increased by 34%.
KMTS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.31 | 232.91B | ||
| ISRG | INTUITIVE SURGICAL INC | 54.68 | 157.78B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.99 | 146.72B | ||
| SYK | STRYKER CORP | 28.82 | 141.56B | ||
| MDT | MEDTRONIC PLC | 16.97 | 120.38B | ||
| BDX | BECTON DICKINSON AND CO | 12.73 | 52.06B | ||
| IDXX | IDEXX LABORATORIES INC | 51.57 | 49.54B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.45 | 44.44B | ||
| RMD | RESMED INC | 28.12 | 39.32B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.56 | 33.11B | ||
| DXCM | DEXCOM INC | 40.54 | 27.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.92 | 25.90B |
Related stock screener links
About KMTS
Company Profile
Kestra Medical Technologies Ltd. operates as a commercial-stage, wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington and currently employs 330 full-time employees. The company went IPO on 2025-03-06. The firm has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The firm's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.
Company Info
KESTRA MEDICAL TECHNOLOGIES
3933 Lake Washington Blvd Ne, Suite 200
Kirkland WASHINGTON US
Employees: 330
Phone: 14252798002
KESTRA MEDICAL TECHNOLOGIES / KMTS FAQ
What is the stock price of KESTRA MEDICAL TECHNOLOGIES today?
The current stock price of KMTS is 24.23 USD. The price increased by 0.46% in the last trading session.
What is the ticker symbol for KESTRA MEDICAL TECHNOLOGIES stock?
The exchange symbol of KESTRA MEDICAL TECHNOLOGIES is KMTS and it is listed on the Nasdaq exchange.
On which exchange is KMTS stock listed?
KMTS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for KESTRA MEDICAL TECHNOLOGIES stock?
12 analysts have analysed KMTS and the average price target is 27.37 USD. This implies a price increase of 12.96% is expected in the next year compared to the current price of 24.23. Check the KESTRA MEDICAL TECHNOLOGIES stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is KESTRA MEDICAL TECHNOLOGIES worth?
KESTRA MEDICAL TECHNOLOGIES (KMTS) has a market capitalization of 1.24B USD. This makes KMTS a Small Cap stock.
How many employees does KESTRA MEDICAL TECHNOLOGIES have?
KESTRA MEDICAL TECHNOLOGIES (KMTS) currently has 330 employees.
What are the support and resistance levels for KESTRA MEDICAL TECHNOLOGIES (KMTS) stock?
KESTRA MEDICAL TECHNOLOGIES (KMTS) has a support level at 24.11 and a resistance level at 24.94. Check the full technical report for a detailed analysis of KMTS support and resistance levels.
Is KESTRA MEDICAL TECHNOLOGIES (KMTS) expected to grow?
The Revenue of KESTRA MEDICAL TECHNOLOGIES (KMTS) is expected to grow by 49.46% in the next year. Check the estimates tab for more information on the KMTS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy KESTRA MEDICAL TECHNOLOGIES (KMTS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of KMTS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of KMTS, evaluating the profitability, health, valuation and growth aspects
- KESTRA MEDICAL TECHNOLOGIES (KMTS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- KESTRA MEDICAL TECHNOLOGIES (KMTS) Sales and EPS estimates to see what analysts future expectations are.
- KESTRA MEDICAL TECHNOLOGIES (KMTS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- KESTRA MEDICAL TECHNOLOGIES (KMTS) Insider and Institutional Ownership to learn about the owners and their transactions.
- KESTRA MEDICAL TECHNOLOGIES (KMTS) Stock Chart to make your own analysis
- KESTRA MEDICAL TECHNOLOGIES (KMTS) Latest news and press-releases to stay up to date.
Does KESTRA MEDICAL TECHNOLOGIES (KMTS) stock pay dividends?
KMTS does not pay a dividend.
What is the Price/Earnings (PE) ratio of KESTRA MEDICAL TECHNOLOGIES (KMTS)?
KESTRA MEDICAL TECHNOLOGIES (KMTS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.6).
What is the Short Interest ratio of KESTRA MEDICAL TECHNOLOGIES (KMTS) stock?
The outstanding short interest for KESTRA MEDICAL TECHNOLOGIES (KMTS) is 10.66% of its float. Check the ownership tab for more information on the KMTS short interest.
KMTS Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to KMTS.
KMTS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to KMTS. KMTS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
KMTS Financial Highlights
Over the last trailing twelve months KMTS reported a non-GAAP Earnings per Share(EPS) of -2.6. The EPS decreased by -25.08% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -48.7% | ||
| ROE | -70.43% | ||
| Debt/Equity | 0.23 |
KMTS Forecast & Estimates
12 analysts have analysed KMTS and the average price target is 27.37 USD. This implies a price increase of 12.96% is expected in the next year compared to the current price of 24.23.
For the next year, analysts expect an EPS growth of -48.74% and a revenue growth 49.46% for KMTS